Insider · CIK 0001279281

Magovcevic-Liebisch Ivana

Reports to the SEC for 7 companies · BILLERICA, MA

sec.gov

Transactions

Companies

Filings

CIK

0001279281

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-02	QTRXQuanterix CorpM Exercise/Conversion	Director	MExercise/Conversion	+4,224 sh	—	—	15,883
2026-10-02	QTRXQuanterix Corp · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,224 sh	—	—	4,352
2026-06-17	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.3K sh	—	—	20,275
2026-05-18	ACRVAcrivon Therapeutics, Inc.A Award	Director	AAward	+9,366 sh	—	—	9,366
2026-01-02	QTRXQuanterix CorpA Award	Director	AAward	+23.4K sh	—	—	43,607
2025-08-05	Vigil Neuroscience, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−223K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−369K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−211K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−405K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−43.3K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−282K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−370K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−463K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−485K sh	—	—	0
2025-06-13	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.3K sh	—	—	20,275
2025-03-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director, President and CEO	AAward	+485K sh	—	—	485,000
2025-01-02	QTRXQuanterix CorpA Award	Director	AAward	+7,435 sh	—	—	20,235
2025-01-02	QTRXQuanterix Corp · Stock Option (Right to Buy)A Award	Director	AAward	+15.8K sh	—	—	15,821
2024-12-19	Vigil Neuroscience, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$1.68	+$8,400	222,687
2024-12-18	Vigil Neuroscience, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$1.67	+$8,350	217,687
2024-12-05	Vigil Neuroscience, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$2.34	+$11.7K	212,687
2024-10-02	QTRXQuanterix CorpA Award	Director	AAward	+12.8K sh	—	—	12,800
2024-10-02	QTRXQuanterix Corp · Common StockA Award	Director	AAward	+27.7K sh	—	—	27,689
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−282K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director, President and CEO	AAward	+282K sh	—	—	282,000
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−370K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director, President and CEO	AAward	+370K sh	—	—	370,000
2024-03-01	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director, President and CEO	AAward	+463K sh	—	—	463,000
2024-02-08	ACRVAcrivon Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.5K sh	—	—	32,500
2023-11-20	Vigil Neuroscience, Inc.P Purchase	Director, President and CEO	PPurchase	+4,000 sh	$3.75	+$15K	207,687
2023-06-22	SYRESpyre Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1.95M sh	—	—	1,950,000
2023-03-01	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director, President and CEO	AAward	+370K sh	—	—	370,000
2022-06-08	ABSIAbsci Corp · Stock Option (right to buy)A Award	Director	AAward	+28.7K sh	—	—	28,700
2022-06-07	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+43K sh	—	—	43,000
2022-05-03	Vigil Neuroscience, Inc.P Purchase	Director, President and CEO	PPurchase	+1,000 sh	$3.94	+$3,940.2	203,687
2022-05-02	Vigil Neuroscience, Inc.P Purchase	Director, President and CEO	PPurchase	+4,000 sh	$3.61	+$14.4K	202,687
2022-03-01	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director, President and CEO	AAward	+282K sh	—	—	282,000
2021-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2021-06-08	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-12-16	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-06-08	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+28.1K sh	—	—	28,100
2019-12-04	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-07	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,400
2018-11-15	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-07-25	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2018-07-25	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-03-22	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+36.8K sh	—	—	36,800
2017-02-28	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2016-11-16	APPLIED GENETIC TECHNOLOGIES CORPP Purchase	Director	PPurchase	+3,000 sh	$9.63	+$28.9K	3,000
2015-11-19	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+6,200 sh	—	—	6,200

Recent filings

Accepted (ET)
Oct 24
Magovcevic-Liebisch Ivana0001279281-26-000003
SEC(opens sec.gov)
Jun 224
Magovcevic-Liebisch Ivana0000905148-26-003034
SEC(opens sec.gov)
May 204
Magovcevic-Liebisch Ivana0000905148-26-002559
SEC(opens sec.gov)
Jan 154
Magovcevic-Liebisch Ivana0001279281-26-000001
SEC(opens sec.gov)
Aug 54
Magovcevic-Liebisch Ivana0000950170-25-102487
SEC(opens sec.gov)
Jun 174
Magovcevic-Liebisch Ivana0000905148-25-002171
SEC(opens sec.gov)
Mar 44
Magovcevic-Liebisch Ivana0000950170-25-032406
SEC(opens sec.gov)
Jan 64
Magovcevic-Liebisch Ivana0001562180-25-000209
SEC(opens sec.gov)
Dec 194
Magovcevic-Liebisch Ivana0000950170-24-138617
SEC(opens sec.gov)
Dec 184
Magovcevic-Liebisch Ivana0000950170-24-138012
SEC(opens sec.gov)

Companies

Address

C/O QUANTERIX CORPORATION 900 MIDDLESEX TURNPIKE

BILLERICA, MA, 01821